TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33986149

Group type: EXPERIMENTAL
Intervention: Original scoring system
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: New scoring system
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: CART model
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Early neurologic clinical examination
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: New CART model
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Early neurologic evaluation
Number of subjects: 364
Study: 32379483

Group type: EXPERIMENTAL
Intervention: High-intensity ultrasonically nebulized distilled water (UNDW) inhalations (1.6 ml/min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-intensity UNDW inhalations (0.5 ml/min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control, 0.9% saline inhalations (1.6 ml/min)
Number of subjects: 24
Study: 35317941

Group type: EXPERIMENTAL
Intervention: Supervised exercise programme (3h per week for 10 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard care (Control Group)
Number of subjects: 76
Study: 33245332

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard medical treatment (SMT)
Number of subjects: 80
Study: 36200522

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (24 weeks of aerobic and resistance exercise)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 0
Study: 32792420

Group type: EXPERIMENTAL
Intervention: Supervised resistance training at home
Number of subjects: 15

Group type: COMPARATOR
Intervention: Supervised resistance training in hospital
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard care with information leaflet
Number of subjects: 15
Study: 32519005

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) - 5 ml/kg body weight of 7.3% NaCl over 60 min
Number of subjects: 101

Group type: COMPARATOR
Intervention: Normal saline (NS) - 0.9% NaCl over 60 min
Number of subjects: 101
Study: 35290444

Group type: EXPERIMENTAL
Intervention: Sutureless aortic valve replacement (Su‐AVR)
Number of subjects: 896

Group type: COMPARATOR
Intervention: Stented sutured bioprosthesis (SAVR)
Number of subjects: 896
Study: 33965268

Group type: EXPERIMENTAL
Intervention: Body dissatisfaction
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Interaction between body dissatisfaction and gender
Number of subjects: 811
Study: 32423706

Group type: EXPERIMENTAL
Intervention: Anticholinergics
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Desmopressin (added if anticholinergics were not satisfactory)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Antidepressant therapy (combined with desmopressin if needed)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Combination treatment including desmopressin
Number of subjects: 154
Study: 34378862

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gel 1% applied inside the implant hex
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no gel applied)
Number of subjects: 40
Study: 32059705

Group type: EXPERIMENTAL
Intervention: De-escalated primary radiotherapy (60 Gy) ± concomitant chemotherapy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) ± de-escalated adjuvant radiotherapy (50-60 Gy based on risk factors)
Number of subjects: 140
Study: 35870710

Group type: EXPERIMENTAL
Intervention: Pelvic radiotherapy (50Gy prescription dose)
Number of subjects: 132
Study: 34401493

Group type: EXPERIMENTAL
Intervention: Flexible fiber carbon dioxide laser (Laser)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Electrocautery (EC)
Number of subjects: 62
Study: 32534807

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate with leucovorin rescue (HDMTX-LR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33866849

Group type: EXPERIMENTAL
Intervention: 4-week training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 62
Study: 32126987

Group type: EXPERIMENTAL
Intervention: Direct patient mailings and in-clinic referrals
Number of subjects: 1432
Study: 36149216

Group type: COMPARATOR
Intervention: Standard Triple Therapy (sTT)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Bismuth-Containing Quadruple Therapy (BQT)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Sequential Therapy (ST)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Hybrid Therapy (HT)
Number of subjects: 303
Study: 34922474

Group type: EXPERIMENTAL
Intervention: Initial extreme gradient-boosting (XGBoost) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Final XGBoost model (after excluding hematological features)
Number of subjects: 0
Study: 34161952

Group type: EXPERIMENTAL
Intervention: Bio-enhanced turmeric formulation (BTF) 1 g/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bio-enhanced turmeric formulation (BTF) 1.5 g/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bio-enhanced turmeric formulation (BTF)
Number of subjects: 60
Study: 32075611

Group type: EXPERIMENTAL
Intervention: Rehabilitation coordinator intervention (RC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 33271057

Group type: EXPERIMENTAL
Intervention: EMG-driven exoneuromusculoskeleton with NMES and mechanical torque assistance
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EMG-driven exoneuromusculoskeleton
Number of subjects: 15

Group type: COMPARATOR
Intervention: No assistance provided
Number of subjects: 15
Study: 32684633

Group type: EXPERIMENTAL
Intervention: Bortezomib-containing induction therapy (IT), high-dose melphalan (MEL200), autologous blood stem cell transplantation (ASCT), consolidation, and maintenance with lenalidomide
Number of subjects: 601
Study: 35796614

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (750 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32620337

Group type: EXPERIMENTAL
Intervention: Soy food intake
Number of subjects: 104
Study: 35381839

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg orally two hours before surgery and 24 hours after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Duloxetine and Placebo
Number of subjects: 60
Study: 33626423

Group type: EXPERIMENTAL
Intervention: Henna application
Number of subjects: 56

Group type: COMPARATOR
Intervention: Henna inert
Number of subjects: 56
Study: 32275033

Group type: EXPERIMENTAL
Intervention: Upper thoracic epidural analgesia (TEA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lower thoracic epidural analgesia (TEA)
Number of subjects: 60
Study: 35768093

Group type: EXPERIMENTAL
Intervention: Tackle Your Tics (n=52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Waiting list condition (n=52)
Number of subjects: 104
Study: 34188908

Group type: EXPERIMENTAL
Intervention: Desarda repair
Number of subjects: 77

Group type: COMPARATOR
Intervention: Lichtenstein repair
Number of subjects: 77
Study: 36410128

Group type: EXPERIMENTAL
Intervention: Comfort Marker 2.0® (CM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lancets
Number of subjects: 100
Study: 34426987

Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for automated hair counting and length measurement
Number of subjects: 288
Study: 33068344

Group type: EXPERIMENTAL
Intervention: Acupuncture at Guanyuan (CV 4) and Zusanli (ST 36) for 15 min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Moxibustion at Guanyuan (CV 4) and Zusanli (ST 36) for 15 min
Number of subjects: 90

Group type: COMPARATOR
Intervention: Blank group (no intervention)
Number of subjects: 90
Study: 36420117

Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 33210787

Group type: EXPERIMENTAL
Intervention: Peri-implantitis
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Peri-implant diseases
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: PPD≥6 mm
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: PPD≥8 mm
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Mucosal dehiscence (MD)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Total OHIP-14Sp sum score
Number of subjects: 99
Study: 34268952

Group type: EXPERIMENTAL
Intervention: Trastuzumab + DOS
Number of subjects: 106

Group type: COMPARATOR
Intervention: DOS
Number of subjects: 106
Study: 32282608

Group type: EXPERIMENTAL
Intervention: Balloon occlusion of the internal iliac arteries
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no balloon occlusion)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Balloon occlusion group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 34391265

Group type: EXPERIMENTAL
Intervention: KT activation (KTact)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sham tape (KTst)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 37
Study: 35979901

Group type: EXPERIMENTAL
Intervention: 15-mL oral solution of aspirin (300 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chewed aspirin tablet (300 mg)
Number of subjects: 0
Study: 33986063

Group type: EXPERIMENTAL
Intervention: Apple
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Watermelon
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cream cracker
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: White bread
Number of subjects: 72
Study: 36345961

Group type: EXPERIMENTAL
Intervention: Augmented reality (AR) app
Number of subjects: 23
Study: 33210993

Group type: EXPERIMENTAL
Intervention: Green tea intake
Number of subjects: 3

Group type: COMPARATOR
Intervention: Water intake
Number of subjects: 3
Study: 33430928

Group type: EXPERIMENTAL
Intervention: Home-based delivery (HBD)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Adherence clubs (AC)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 104
Study: 32875582

Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-stage randomized trial design
Number of subjects: 0
Study: 35815622

Group type: EXPERIMENTAL
Intervention: Competency-driven training (CDT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Training-as-usual (TAU)
Number of subjects: 24
Study: 33742282

Group type: EXPERIMENTAL
Intervention: HUGS intervention (4-session, group-based mother-infant interaction intervention)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control playgroup (following cognitive-behavioral therapy for PND)
Number of subjects: 77
Study: 32818720

Group type: EXPERIMENTAL
Intervention: Mind-body resiliency group intervention (8 sessions, in-person)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mind-body resiliency group intervention
Number of subjects: 23
Study: 35017606

Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the non-dominant nasal airway
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the dominant nasal airway
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the left nostril
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unilateral nostril breathing (UNB) using the right nostril
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baseline (resting phase)
Number of subjects: 30
Study: 34496907

Group type: EXPERIMENTAL
Intervention: External stenting of saphenous vein graft
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional suggestion to external stenting
Number of subjects: 0
Study: 34498822

Group type: EXPERIMENTAL
Intervention: Flywheel iso-inertial resistance training (FW)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional gravity-dependent resistance training (GD)
Number of subjects: 24
Study: 33029843

Group type: EXPERIMENTAL
Intervention: Positive diagnostic strategy (limited blood tests)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Strategy of exclusion (extensive blood tests, fecal samples for intestinal parasites, and sigmoidoscopy with biopsies)
Number of subjects: 302
Study: 34773985

Group type: EXPERIMENTAL
Intervention: High protein intake and early exercise (HPE)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Standard nutrition care and routine physiotherapy (Control)
Number of subjects: 181
Study: 32776891

Group type: EXPERIMENTAL
Intervention: Controlled Differential Evolution (CDE) algorithm with Support Vector Machine (SVM) classification
Number of subjects: 205
Study: 35898575

Group type: EXPERIMENTAL
Intervention: 10 minutes of stair climbing and descending (SCD) at a self-selected comfortable pace
Number of subjects: 30

Group type: COMPARATOR
Intervention: Seated control condition
Number of subjects: 30
Study: 35170885

Group type: EXPERIMENTAL
Intervention: Prayer (reciting for 10 minutes three times daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ginger (250 mg capsules plus 20 ml water after each meal)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (placebo starch capsules, 250 mg daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prayer
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ginger
Number of subjects: 120
Study: 35318971

Group type: EXPERIMENTAL
Intervention: 3D Compressed-Sensing Fluid and White Matter Suppression (CS-FLAWS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 2D T2-weighted imaging (reference)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 3D CS-FLAWS in patients who underwent sagittal T2 + short tau inversion recovery imaging
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 3D CS-FLAWS
Number of subjects: 58
Study: 33031520

Group type: EXPERIMENTAL
Intervention: Human amnion‐chorion membrane
Number of subjects: 43

Group type: COMPARATOR
Intervention: Collagen membrane
Number of subjects: 43
Study: 32366241

Group type: EXPERIMENTAL
Intervention: Rectal STI test selection
Number of subjects: 431
Study: 34135189

Group type: EXPERIMENTAL
Intervention: Iodized salt consumption (>15 ppm)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Urinary iodine concentration (UIC)
Number of subjects: 202
Study: 32697560

Group type: EXPERIMENTAL
Intervention: Photochromic contact lens
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonphotochromic control
Number of subjects: 60
Study: 34698704

Group type: EXPERIMENTAL
Intervention: Infant Mental Health Home Visiting (IMH‐HV) treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 62
Study: 33682353

Group type: EXPERIMENTAL
Intervention: Biologic therapy (a biologic disease-modifying antirheumatic drug plus methotrexate)
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Triple therapy (methotrexate plus sulfasalazine plus hydroxychloroquine/chloroquine)
Number of subjects: 1502
Study: 36037456

Group type: EXPERIMENTAL
Intervention: MI+st‐SES (sensory threshold somatosensory electrical stimulation) during MI tasks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (performed MI tasks only)
Number of subjects: 30
Study: 34440974

Group type: EXPERIMENTAL
Intervention: Virtual therapy (VR) in an eight-week cardiac rehabilitation program
Number of subjects: 43

Group type: COMPARATOR
Intervention: Schultz's autogenic training (control group)
Number of subjects: 43
Study: 35240087

Group type: EXPERIMENTAL
Intervention: SBRT plus pembrolizumab and trametinib
Number of subjects: 170

Group type: COMPARATOR
Intervention: SBRT plus gemcitabine
Number of subjects: 170
Study: 32545074

Group type: EXPERIMENTAL
Intervention: Perceived benefits
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Perceived barriers
Number of subjects: 232

Group type: COMPARATOR
Intervention: Perceived threats
Number of subjects: 232
Study: 35307850

Group type: EXPERIMENTAL
Intervention: P22-TAB (250 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: P22-CAP (250 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: P01-CAP (250 mg)
Number of subjects: 12
Study: 32311936

Group type: EXPERIMENTAL
Intervention: Perinatal individualized interventions based on self-efficacy theory
Number of subjects: 226

Group type: COMPARATOR
Intervention: Usual care for lactation support
Number of subjects: 226
Study: 34896294

Group type: EXPERIMENTAL
Intervention: Clinician education plus behavioral‐economics‐informed clinical decision support (CDS)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Clinician education alone
Number of subjects: 374
Study: 34890377

Group type: EXPERIMENTAL
Intervention: 10 days antibiotic therapy (SDR group)
Number of subjects: 113

Group type: COMPARATOR
Intervention: 14 days antibiotic therapy (LDR group)
Number of subjects: 113
Study: 35396075

Group type: EXPERIMENTAL
Intervention: Cervical noninvasive vagus nerve stimulation (nVNS) for two weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment for two weeks
Number of subjects: 16
Study: 34925204

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) combined with conventional, individualised rehabilitation therapy.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional, individualised rehabilitation therapy (Control group).
Number of subjects: 40
Study: 36335393

Group type: EXPERIMENTAL
Intervention: Subacromial decompression (Group SAD)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Debridement of calcifications (Group D)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Debridement of calcifications with SAD (Group D + SAD)
Number of subjects: 69
Study: 32307089

Group type: EXPERIMENTAL
Intervention: Anemic HFpEF patients
Number of subjects: 0
Study: 615803878

Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy with gemcitabine, dexamethasone, cisplatin (GDP) or dexamethasone, cytarabine, cisplatin (DHAP) followed by autologous stem cell transplantation (ASCT)
Number of subjects: 177
Study: 33891570

Group type: EXPERIMENTAL
Intervention: Acupressure on three acupuncture points (LI4, SP6, ST36) for three minutes twice daily for four weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study: 33618735

Group type: EXPERIMENTAL
Intervention: Senyuman Indah Milik Semua Programme (SIMSP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Existing preschool oral healthcare programme (POHP)
Number of subjects: 28
Study: 34959080

Group type: EXPERIMENTAL
Intervention: Chronic liver disease measured by the Dallas Steatosis Index (DSI) in ACCORD (median DSI 1.0, IQR 0.2-1.8)
Number of subjects: 5859

Group type: EXPERIMENTAL
Intervention: Self-reported chronic liver disease in SPRINT
Number of subjects: 5859
Study: 34136057

Group type: EXPERIMENTAL
Intervention: Play therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Hugo's point massage
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 33308257

Group type: EXPERIMENTAL
Intervention: TB treatment adherence intervention (educational outreach, point-of-care reminder tool, peer support network)
Number of subjects: 798

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 798
Study: 35971596

Group type: EXPERIMENTAL
Intervention: AZD9977 100 mg once daily for 14 days, up-titrated to 200 mg for another 14 days
Number of subjects: 68

Group type: COMPARATOR
Intervention: Spironolactone 25 mg once daily for 14 days, up-titrated to 50 mg for another 14 days
Number of subjects: 68
Study: 34886680

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg once daily
Number of subjects: 15076

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg once daily
Number of subjects: 15076
Study: 32272243

Group type: EXPERIMENTAL
Intervention: Budesonide Oral Suspension (BOS) 2.0 mg twice daily for 12 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 35692186

Group type: EXPERIMENTAL
Intervention: Tetrahydrocannabinol (dose = 13‐49 mg)
Number of subjects: 85
Study: 34836199

Group type: EXPERIMENTAL
Intervention: Randomized infant formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Greater velocities of weight gain during early infancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower access to snacks as toddlers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Energy and added sugar intake
Number of subjects: 0
Study: 33291249

Group type: EXPERIMENTAL
Intervention: Nominal group technique (NGT) sessions
Number of subjects: 33
Study: 35704345

Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy
Number of subjects: 2215

Group type: COMPARATOR
Intervention: Combination therapy with rivaroxaban and antiplatelet therapy
Number of subjects: 2215
Study: 33279874

Group type: EXPERIMENTAL
Intervention: Erlotinib plus bevacizumab (15 mg/kg every 21 days)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Erlotinib monotherapy (150 mg once daily)
Number of subjects: 152
Study: 35369996

Group type: EXPERIMENTAL
Intervention: Individual nurse-led education session on HF self-management during hospitalization and three telephone calls after discharge
Number of subjects: 122

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 122
Study: 33903059

Group type: EXPERIMENTAL
Intervention: Experiences of discrimination based on age, sex, and race or ethnicity.
Number of subjects: 96110

Group type: EXPERIMENTAL
Intervention: Experiences of harassment related to race or ethnicity.
Number of subjects: 96110

Group type: EXPERIMENTAL
Intervention: Intersectionality analysis of discrimination and harassment experiences.
Number of subjects: 96110

Group type: EXPERIMENTAL
Intervention: Harassment experiences from customers or patients.
Number of subjects: 96110

Group type: EXPERIMENTAL
Intervention: Satisfaction with reporting discrimination and harassment.
Number of subjects: 96110
Study: 32171084

Group type: EXPERIMENTAL
Intervention: Real-time computer-aided system (ENDOANGEL)
Number of subjects: 0
Study: 36054477

Group type: EXPERIMENTAL
Intervention: Preoperative NSAIDs (administered from 24 hours pre-surgery to day 7 post-surgery)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Postoperative NSAIDs (administered from 12 hours post-surgery to day 7 post-surgery)
Number of subjects: 204
Study: 33021047

Group type: EXPERIMENTAL
Intervention: Live lecture
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Video recorded lecture
Number of subjects: 94

Group type: COMPARATOR
Intervention: Audio recorded lecture
Number of subjects: 94